主要呈现形式:
1.代表性论文
(1)Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. 2013; 381(9882): 2024-2032;
(2)An inactivated enterovirus 71 vaccine in healthy children. The New England Journal of Medicine. 2014; 370(9): 829-837;
(3)Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. The New England Journal of Medicine, 2014; 370(9): 818-828.
2.发明专利
(1)EV71病毒广谱性单克隆抗体及其应用,CN200910131558,2009年4月3日授权;
(2)一种EV-71病毒毒种、人用灭活疫苗及其制备方法,CN101402944,2009年4月8日授权。
3.产品
(1)肠道病毒71型灭活疫苗(人二倍体细胞),国药准字S20150016;
(2)肠道病毒71型灭活疫苗(Vero细胞),国药准字S20150017;
(3)肠道病毒71型灭活疫苗(Vero细胞),国药准字S20160008。